Provera side effects insomnia

Medscape - Indication-specific dosing for Depo-Provera, Depo-SubQ Provera 104 (medroxyprogesterone), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. Estrogen plus progestin may increase your chance of getting certain cancers, including cancer of the breast. If you have or have had cancer, talk with your health care provider about whether you should use PROVERA. Provera (Medroxyprogesterone Acetate Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Find patient medical information for Medroxyprogesterone (Provera, Depo-Provera, and others) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user. Provera is a progestin hormone used to treat menstrual periods that have stopped, abnormal uterine bleeding and to reduce the chances of getting uterine cancer. PROVERA tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine. PROVERA® (medroxyprogesterone acetate) medication page for patients to search for scientific information & prescribing information about Pfizer medications in the US. PROVERA is used to treat menstrual periods that have stopped or to treat abnormal uterine bleeding. Talk with your doctor about whether PROVERA is right for you. The depo shot (AKA Depo-Provera) is an injection you get once every 3 months. It’s a safe, convenient, and private birth control method that works really well if you always get it on time. Provera is a form of progesterone (a hormone) that is used to treat conditions such as absent or irregular menstrual periods, or abnormal uterine bleeding. Provera is also used to decrease the risk of endometrial hyperplasia (a condition that may lead to uterine cancer) while taking estrogens.

Meta: